Vanguard Trims Sarepta Stake to 11.2% as of Dec 29, 2023

TL;DR

**Vanguard slightly reduced its stake in Sarepta to 11.2%, a minor but notable shift.**

AI Summary

The Vanguard Group, a major investment firm, filed an amendment (SC 13G/A) on February 13, 2024, updating its ownership in Sarepta Therapeutics Inc. As of December 29, 2023, Vanguard reported beneficial ownership of 10,233,485 shares of Sarepta's Common Stock, representing 11.2% of the company. This filing indicates a slight decrease in Vanguard's percentage ownership from its previous filing, which matters to investors as large institutional holdings can influence stock stability and investor confidence.

Why It Matters

Large institutional ownership changes can signal shifts in confidence from major investors, potentially impacting stock price and liquidity for Sarepta Therapeutics.

Risk Assessment

Risk Level: low — A minor adjustment in institutional ownership by a passive investor like Vanguard typically poses low risk to the company's stock.

Analyst Insight

Investors should note that while Vanguard remains a significant shareholder, the slight reduction in its stake might warrant a closer look at Sarepta's recent performance and future outlook, though it's not a strong buy or sell signal on its own.

Key Numbers

• 10,233,485 — Shares Beneficially Owned (This is the total number of Sarepta Therapeutics Common Stock shares Vanguard reported owning as of December 29, 2023.)
• 11.2% — Percentage of Class (This represents Vanguard's total ownership percentage of Sarepta Therapeutics' Common Stock, indicating a significant but slightly reduced stake.)
• 803607100 — CUSIP Number (This unique identifier helps track Sarepta Therapeutics' Common Stock.)

Key Players & Entities

• The Vanguard Group (company) — reporting person and institutional investor
• Sarepta Therapeutics Inc (company) — subject company whose securities are being reported
• 10,233,485 (dollar_amount) — number of shares beneficially owned by Vanguard
• 11.2% (dollar_amount) — percentage of class beneficially owned by Vanguard
• December 29, 2023 (date) — date of event requiring the filing

Forward-Looking Statements

• Vanguard will maintain a significant, albeit potentially fluctuating, stake in Sarepta Therapeutics due to its passive investment strategy. (The Vanguard Group) — high confidence, target: Next 12-24 months

FAQ

Filing Documents

• tv01876-sareptatherapeuticsi.htm (SC 13G/A) — 11KB
• 0001104659-24-021893.txt ( ) — 13KB

(a) - Name of Issuer

Item 1(a) - Name of Issuer: Sarepta Therapeutics Inc

(b) - Address of Issuer's Principal Executive Offices

Item 1(b) - Address of Issuer's Principal Executive Offices: 215 First Street, Suite 415 Cambridge, MA 02142

(a) - Name of Person Filing

Item 2(a) - Name of Person Filing: The Vanguard Group - 23-1945930

(b) – Address of Principal Business Office or, if none, residence

Item 2(b) – Address of Principal Business Office or, if none, residence: 100 Vanguard Blvd. Malvern, PA 19355

(c) – Citizenship

Item 2(c) – Citizenship: Pennsylvania

(d) - Title of Class of Securities

Item 2(d) - Title of Class of Securities: Common Stock

(e) - CUSIP Number

Item 2(e) - CUSIP Number 803607100

- Type of Filing

Item 3 - Type of Filing: This statement is being filed pursuant to Rule 13d-1. An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E).

- Ownership

Item 4 - Ownership: (a) Amount Beneficially Owned: (b) Percent of Class: (c) Number of shares as to which such person has: (i) sole power to vote or direct to vote: (ii) shared power to vote or direct to vote: (iii) sole power to dispose of or to direct the disposition of: (iv) shared power to dispose or to direct the disposition of: Comments: The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.

- Ownership of Five Percent or Less of a Class

Item 5 - Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following

- Ownership of More Than Five Percent on Behalf of Another Person

Item 6 - Ownership of More Than Five Percent on Behalf of Another Person: The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein. No one other person's interest in the securities reported herein is more than 5%. Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company: Not applicable

- Identification and Classification of Members of Group

Item 8 - Identification and Classification of Members of Group: Not applicable

- Notice of Dissolution of Group

Item 9 - Notice of Dissolution of Group: Not applicable

- Certification

Item 10 - Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: February 13, 2024 By /s/ Ashley Grim Name: Ashley Grim Title: Head of Global Fund Administration

View Full Filing

View this SC 13G/A filing on SEC EDGAR